Evidence map›Paper›PMID 42380117›Full record

ArticleNature communications2026

Unified bilayer membranes with mechanically reinforced interface for stage-adaptive bone regeneration.

Yuhan Du, Yangyi Nie, Zhiheng Luo, Junjie Deng, Zili Xu, Yuyang Zhang, Chenyu Gao, Yujie Liu, Xiangcheng Lei, Jing Long and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Yuhan DuCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Yangyi NieCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zhiheng LuoTianjin Hospital, Tianjin University, Tianjin, China.
Junjie DengCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zili XuCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Yuyang ZhangCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Chenyu GaoThe Brain Cognition and Brain Disease institute of Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.ORCID http://orcid.org/0000-0001-6689-7293
Yujie LiuCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Xiangcheng LeiCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Jing LongCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Cairong LiCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zhenyu YaoCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Wei ZhangCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.ORCID http://orcid.org/0000-0002-5663-4438
Ling QinCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.ORCID http://orcid.org/0000-0001-6173-6167
Yuanchi ZhangCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. zhangyc@siat.ac.cn.ORCID http://orcid.org/0000-0001-7668-8428
Yuxiao LaiCentre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. yx.lai@siat.ac.cn.ORCID http://orcid.org/0000-0002-8648-6595

Funding

National Natural Science Foundation of China (National Science Foundation of China) 52203204National Natural Science Foundation of China (National Science Foundation of China) 82525040National Natural Science Foundation of China (National Science Foundation of China) U24A20374
6 · The paper itself

Abstract

Guided bone regeneration using double-layered membranes is often hindered by poor interfacial integration, insufficient stability, and limited adaptability to regulate the complex healing process. Herein, we develop a unified bilayer membrane featuring a reinforced dual-crosslinking interface between barrier and porous layers through a homogeneous isomeric in-situ fabrication strategy. Its superior mechanical strength (~156 MPa in dry state and ~8.6 MPa in wet state) ensures the long-term degradation stability and bioactivity in vivo. Combined with sequentially released bioactive components, we show that the unified bilayer membrane regulates antibacterial functions, immunomodulation, neurovascularization, and osteogenesis, thereby enabling stage-adaptive bone regeneration. We test in a rat critical-sized cranial defect model to demonstrate that the membrane significantly outperforms the clinical collagen membrane, achieving ~2.7-fold greater bone volume regeneration after 8 weeks. This work further elucidates the spatiotemporal osteogenic mechanisms of the unified bilayer membrane, which constructs a well-integrated regenerative microenvironment and promotes a tightly interconnected neurovascular-osteogenic communication network during stage-adaptive bone repair.

Indexed as

Bone RegenerationGuided Tissue RegenerationMembranes, ArtificialAnimalsCollagenMaleOsteogenesisPorosityRatsRats, Sprague-DawleySkullTissue ScaffoldsCollagenMembranes, Artificial

Identifiers

PMID42380117
PMCPMC13462358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.